The Idylla™ ctBRAF Mutation Assay, performed on the Biocartis Idylla™ System, is a for “Research Use Only” Assay for the semi-quantitative detection of V600E/E2/D and V600K/R/M mutations in codon 600 of the BRAF gene. The Idylla™ ctBRAF Mutation Assay extracts and amplifies BRAF circulating tumor DNA (ctDNA) from 1 ml of plasma.
Prof. B. Neyns, M.D., Ph.D
Medical Oncology, UZ Brussels, Belgium
"The Idylla™ System has the potential to allow the start of targeted therapy within a time window of less than 24 hours following the diagnosis of metastasis by analyzing tumor or ctDNA, thereby saving precious time."
Not for sale in the USA and Canada. For product availability in your country please contact us via firstname.lastname@example.org.